Journal profile · Chemistry, Multidisciplinary
Journal of Pharmaceutical Sciences
ISSN 0022-3549 · eISSN 1520-6017 · John Wiley and Sons Inc. · UNITED STATES · Monthly · Founded 1961
Journal of Pharmaceutical Sciences: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.77; hybrid open access; APC about USD 3,620; median 92 days to acceptance (147 articles, last 24 months); community-reported acceptance: fairly easy; 1,033 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Pharmaceutical Sciences is published by John Wiley and Sons Inc. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Analytical Chemistry and Chromatography, Drug Solubulity and Delivery Systems and Analytical Methods in Pharmaceuticals, together about 33.9% of its articles. Its main subfields are Pharmaceutical Science. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Pharmaceutical Sciences (www.jpharmsci.org)The Journal of Pharmaceutical Sciences focuses on two major questions of importance to pharmaceutical scientists: (i) What are the physical and biological barriers that limit the access of drugs to their therapeutic targets?; and (ii) How can drugs, excipients, traditional formulations, and novel drug delivery systems be designed to minimize the frequency and severity of adverse effects (i.e., including the prediction and preclusion of immunogenicity), maximize the therapeutic index, increase global access, and to minimize costs? Answers to these questions have in the past and will in the future be forthcoming from research in a variety of scientific disciplines including but not limited to the following: physical pharmacy; pharmaceutics; pharmaceutical technology; drug delivery; pharmaceutical engineering; materials science; nanotechnology; animal, human, cellular and molecular biopharmaceutics; animal and human pharmacokinetics, pharmacodynamics and pharmacogenomics; drug metabolism and transport; biotechnology; medical chemistry, including drug design and prodrug strategies; biophysical chemistry; analytical and bioanalytical chemistry; physical organic, organic, and computational chemistry; molecular modeling; immunology; biochemistry; and cell and molecular biology.
From the journal's Aims & Scope
Research area (LetPub): Chemistry, Multidisciplinary
Editor-in-chief Kenneth L. AudusPublisher website
Editorial board by country: 5 in mainland China (about 2%); most named United States 177, Japan 29, United Kingdom 21, Italy 18, Germany 11 (313 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Analytical Chemistry and ChromatographyChemistry12.8%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics12%
- Analytical Methods in PharmaceuticalsChemistry9%
- Protein purification and stabilityBiochemistry, Genetics and Molecular Biology6.9%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics5.9%
- Crystallization and Solubility StudiesMaterials Science5.8%
- Drug Transport and Resistance MechanismsMedicine5.3%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Chemistry, Medicinal | Zone 3 |
| Minor | Chemistry, Multidisciplinary | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Chemistry, Medicinal | Zone 3 |
| Minor | Chemistry, Multidisciplinary | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Chemistry, Medicinal | Zone 3 |
| Minor | Chemistry, Multidisciplinary | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.77LetPub ·
- Impact factor (publisher)
- 3.9Publisher website ·
- CiteScore 2026-06
- 6.6LetPub ·
- CiteScore (publisher)
- 6.6Publisher website ·
- SJR 2026-06
- 0.71LetPub ·
- SNIP 2026-06
- 1.05LetPub ·
- h-index
- 159LetPub ·
- h-index
- 279OpenAlex ·
- i10-index
- 15,623OpenAlex ·
- 2-year mean citedness
- 1.24OpenAlex ·
- Self-citation rate
- 10.3%LetPub ·
- Share of gold OA articles
- 13.6%LetPub ·
Volume
- Articles per year
- 385LetPub ·
Articles by year OpenAlex count · 29,574 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 1,568 | 1,348 | 137 |
| 2025 | 1,033 | 761 | 970 |
| 2024 | 383 | 143 | 2,600 |
| 2023 | 334 | 155 | 3,723 |
| 2022 | 340 | 140 | 5,188 |
| 2021 | 388 | 131 | 7,760 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
92 daysMedian, submission to acceptance · P25–P75 63 days – 125 days
- Acceptance to online
- median 5 days (147 articles)
- Submission to online
- median 99 days
- Sample
- 147 articles with submission and acceptance dates (817 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2.3 monthsLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- First decision after review
- 29 daysPublisher website ·
- Submission to acceptance
- 92 daysPublisher website ·
- Acceptance to publication
- 3 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,620 / EUR 3,390 / GBP 2,900 / JPY 448,990 | — | — | |
| Publisher website | USD 3,880 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted5
- commentaryThe Editor-in-Chief and one Editor, as well as members of the Journal's Editorial Advisory Board and independent experts, will review most manuscripts submitted…Length not stated
- editorialThe Editor-in-Chief and one Editor, as well as members of the Journal's Editorial Advisory Board and independent experts, will review most manuscripts submitted…Length not stated
- rapid communicationThe Editor-in-Chief and one Editor, as well as members of the Journal's Editorial Advisory Board and independent experts, will review most manuscripts submitted…Length not stated
- research articleThe Editor-in-Chief and one Editor, as well as members of the Journal's Editorial Advisory Board and independent experts, will review most manuscripts submitted…Length not stated
- reviewThe Editor-in-Chief and one Editor, as well as members of the Journal's Editorial Advisory Board and independent experts, will review most manuscripts submitted…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Changes to authorship
The editors of this journal generally will not consider changes to authorship once a manuscript has been submitted. It is important that authors carefully consider the authorship list and order of authors and provide a definitive author list at submission. The policy of this journal around authorship changes:All authors must be listed in the manuscript and their details entered into the submission…
Source ↗Publisher website ·- Conflicts of interest Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Subscribers may reproduce tables of contents or prepare lists of articles includ…
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Peer review Online Submission and Peer Review
Original, unpublished work only; not under consideration elsewhere. Model summary
Authors should ensure that papers conform to the scientific and style instructions given below. In order to expedite the publication process the Journal requires that manuscripts be submitted online at https://www.editorialmanager.com/xphsJournal of Pharmaceutical Sciences has a completely digital submission, review, and production process. We therefore ask for production-quality files at the time…
Source ↗Publisher website ·- Preprints Preprint references
Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- John Wiley and Sons Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1961
- ISSN
- 0022-3549
- Electronic ISSN
- 1520-6017
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Journal of Pharmaceutical Sciences
What CAS zone is Journal of Pharmaceutical Sciences in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Pharmaceutical Sciences is in Zone 3 of Medicine, and in Zone 3 of the minor category Chemistry, Medicinal / Chemistry, Multidisciplinary / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Pharmaceutical Sciences?
The latest impact factor listed by LetPub is 3.77; CiteScore 6.6, h-index 279.
How long does peer review take at Journal of Pharmaceutical Sciences?
Based on the dates recorded on 147 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 92 days (interquartile range 63–125 days); authors report an average review time of about 2.3 months; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of Pharmaceutical Sciences based?
Of the 313 board members whose country the journal's board page names, 5 (about 2%) are in mainland China; the countries named most often are United States (177), Japan (29) and United Kingdom (21). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Pharmaceutical Sciences?
According to LetPub and DOAJ records, Journal of Pharmaceutical Sciences is indexed in SCIE and Scopus.
Is Journal of Pharmaceutical Sciences open access, and what is the APC?
Journal of Pharmaceutical Sciences is a hybrid journal. For open-access publication: APC about USD 3,620.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .